Celldex Therapeutics Inc CLDX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/24/24 EDT
37.02quote price arrow down-0.75 (-1.99%)
Volume
344,944
52 week range
22.11 - 53.18
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close37.02
  • 52 Week High53.18
  • 52 Week High Date03/04/24
  • 52 Week Low22.11
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap2.384B
  • Shares Out64.40M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta1.59
  • YTD % Change-6.66

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close37.02
  • 52 Week High53.18
  • 52 Week High Date03/04/24
  • 52 Week Low22.11
  • 52 Week Low Date10/30/23
  • Market Cap2.384B
  • Shares Out64.40M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta1.59
  • YTD % Change-6.66

RATIOS/PROFITABILITY

  • EPS (TTM)-2.91
  • P/E (TTM)-12.73
  • Fwd P/E (NTM)-12.86
  • EBITDA (TTM)-139.034M
  • ROE (TTM)-37.45%
  • Revenue (TTM)6.883M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,054.76%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Celldex Therapeutics Inc

 

Profile

MORE
Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on exploring the science of mast cell biology and the development of transformative therapeutics for patients. Its drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its Barzolvolimab, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is...
Karen Shoos
Non-Executive Independent Chairman of the Board
Anthony Marucci
President, Chief Executive Officer, Director
Sam Martin CPA
Chief Financial Office, Senior Vice President, Secretary
Tibor Keler Ph.D.
Executive Vice President, Chief Scientific Officer
Address
53 Frontage Road, Suite 220
Hampton, NJ
08827
United States

Top Peers

SYMBOLLASTCHG%CHG
RNA
Avidity Biosciences Inc
25.09-0.05-0.20%
KROS
Keros Therapeutics Inc
56.24+1.05+1.90%
GERN
Geron Corp
3.58+0.08+2.29%
RCKT
Rocket Pharmaceuticals Inc
23.63-0.04-0.17%
DYN
Dyne Therapeutics Inc
24.98-0.46-1.81%